*Department of Sociology, University of Chicago
†Departments of Medicine, Health Studies and Psychiatry, University of Chicago
‡Center for Health Statistics, University of Chicago, Chicago, IL
§Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health
∥Department of Medicine, Section of General Internal Medicine, Johns Hopkins Medicine, Baltimore, MD
¶Department of Pharmacy Practice, University of Illinois at Chicago School of Pharmacy, Chicago, IL
G.C.A. is supported by awards from the Agency for Healthcare Research and Quality (K08 HS15699; RO1 HS0189960).
The statements, findings, conclusions, views, and opinions contained and expressed in this article are based in part on data obtained under license from the following IMS Health Incorporated information service(s): National Disease and Therapeutic Index (1998–2009), Integrated Promotion Services (1998–2009), IMS Health Incorporated. All Rights Reserved. The statements, findings, conclusions, views, and opinions contained and expressed herein are not necessarily those of IMS Health Incorporated or any of its affiliated or subsidiary entities.
G.C.A. is a consultant for IMS Health. R.G. has provided expert testimony regarding the association between antidepressants, antiepileptics and suicide for the U.S. Department of Justice, Wyeth and Pfizer and C.G. declares no conflict of interest.
Reprints: G. Caleb Alexander, MD, MS, Department of Epidemiology, Section of General Internal Medicine, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street W6035, Baltimore, MD 21205. E-mail: [email protected].
